Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exagen (XGN) Non Operating Income (2018 - 2023)

Historic Non Operating Income for Exagen (XGN) over the last 6 years, with Q3 2023 value amounting to $211000.0.

  • Exagen's Non Operating Income fell 3775.81% to $211000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $1.0 million, marking a year-over-year increase of 18324.18%. This contributed to the annual value of $16000.0 for FY2021, which is 9837.4% down from last year.
  • As of Q3 2023, Exagen's Non Operating Income stood at $211000.0, which was down 3775.81% from $476000.0 recorded in Q2 2023.
  • Over the past 5 years, Exagen's Non Operating Income peaked at $689000.0 during Q2 2020, and registered a low of -$5000.0 during Q2 2021.
  • For the 5-year period, Exagen's Non Operating Income averaged around $149764.7, with its median value being $71000.0 (2019).
  • In the last 5 years, Exagen's Non Operating Income plummeted by 10072.57% in 2021 and then soared by 1120000.0% in 2022.
  • Over the past 5 years, Exagen's Non Operating Income (Quarter) stood at $246000.0 in 2019, then tumbled by 100.41% to -$1000.0 in 2020, then skyrocketed by 1600.0% to $15000.0 in 2021, then soared by 2160.0% to $339000.0 in 2022, then tumbled by 37.76% to $211000.0 in 2023.
  • Its Non Operating Income was $211000.0 in Q3 2023, compared to $476000.0 in Q2 2023 and $339000.0 in Q3 2022.